This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Understanding ‘science and the public’
Go to paperABSTRACT: Public acceptance of the products of biotechnology is an important issue for the industry. T…

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Festo: The plague continues
Go to paperABSTRACT: This paper reviews the law on the doctrine of equivalence and prosecution history estoppel and explores…

DrugPatentWatch now contains the most complete resources for pharmaceutical drug patents, expired and acrive, both in the United States and

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Startup America: What it includes and opportunities for innovators

Go to paper

ABSTRACT:   

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

• Management
• Policy
• Finance
• Law
• Regulation
• Bioethics

For more information, see the Journal of Commercial Biotechnology website

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Regulatory Submissions Trends Survey 2002
Go to paperABSTRACT: This Regulatory Submissions Trends Survey, conducted by CDC Solutions in December 2002, t…

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Biotechnology: The underutilised tool in the fight for global health and security
Go to paperABSTRACT: Biotechnology companies can contribute to developi…

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement
Go to paperABSTRACT: Beacon Sciences is an excellent example of how te…

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s